These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36809055)

  • 21. A Deep Learning Mammography-based Model for Improved Breast Cancer Risk Prediction.
    Yala A; Lehman C; Schuster T; Portnoi T; Barzilay R
    Radiology; 2019 Jul; 292(1):60-66. PubMed ID: 31063083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of Estimated Lifetime Breast Cancer Risk Among Women Undergoing Screening Mammography.
    Niell BL; Augusto B; McIntyre M; Conley CC; Gerke T; Roetzheim R; Garcia J; Vadaparampil ST
    AJR Am J Roentgenol; 2021 Jul; 217(1):48-55. PubMed ID: 33978450
    [No Abstract]   [Full Text] [Related]  

  • 23. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
    Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
    Elife; 2023 Mar; 12():. PubMed ID: 36971353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Joint relative risks for estrogen receptor-positive breast cancer from a clinical model, polygenic risk score, and sex hormones.
    Shieh Y; Hu D; Ma L; Huntsman S; Gard CC; Leung JWT; Tice JA; Ziv E; Kerlikowske K; Cummings SR
    Breast Cancer Res Treat; 2017 Nov; 166(2):603-612. PubMed ID: 28791495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Tyrer-Cuzick Model Inaccurately Predicts Invasive Breast Cancer Risk in Women With LCIS.
    Valero MG; Zabor EC; Park A; Gilbert E; Newman A; King TA; Pilewskie ML
    Ann Surg Oncol; 2020 Mar; 27(3):736-740. PubMed ID: 31559544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast cancer risk stratification in women of screening age: Incremental effects of adding mammographic density, polygenic risk, and a gene panel.
    Evans DGR; van Veen EM; Harkness EF; Brentnall AR; Astley SM; Byers H; Woodward ER; Sampson S; Southworth J; Howell SJ; Maxwell AJ; Newman WG; Cuzick J; Howell A
    Genet Med; 2022 Jul; 24(7):1485-1494. PubMed ID: 35426792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical applicability of the Polygenic Risk Score for breast cancer risk prediction in familial cases.
    Lakeman IMM; Rodríguez-Girondo MDM; Lee A; Celosse N; Braspenning ME; van Engelen K; van de Beek I; van der Hout AH; Gómez García EB; Mensenkamp AR; Ausems MGEM; Hooning MJ; Adank MA; Hollestelle A; Schmidt MK; van Asperen CJ; Devilee P
    J Med Genet; 2023 Apr; 60(4):327-336. PubMed ID: 36137616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Model for Predicting Breast Cancer Risk in Women With Atypical Hyperplasia.
    Degnim AC; Winham SJ; Frank RD; Pankratz VS; Dupont WD; Vierkant RA; Frost MH; Hoskin TL; Vachon CM; Ghosh K; Hieken TJ; Carter JM; Denison LA; Broderick B; Hartmann LC; Visscher DW; Radisky DC
    J Clin Oncol; 2018 Jun; 36(18):1840-1846. PubMed ID: 29676945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk, Prognostic Factors and Nomograms for Bone Metastasis in Young Females with Breast Cancer: A Large Cohort Retrospective Study.
    Liu Z; Xue J; Liu K; Fan Z; Liu D; Wang D
    Altern Ther Health Med; 2023 Jan; 29(1):182-190. PubMed ID: 36074969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive model algorithms identifying early and advanced stage ER+/HER2- breast cancer in claims data.
    Beachler DC; de Luise C; Yin R; Gangemi K; Cochetti PT; Lanes S
    Pharmacoepidemiol Drug Saf; 2019 Feb; 28(2):171-178. PubMed ID: 30411431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and validation of polygenic risk scores for prediction of breast cancer and breast cancer subtypes in Chinese women.
    Hou C; Xu B; Hao Y; Yang D; Song H; Li J
    BMC Cancer; 2022 Apr; 22(1):374. PubMed ID: 35395775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of the breast cancer surveillance consortium model of breast cancer risk.
    Tice JA; Bissell MCS; Miglioretti DL; Gard CC; Rauscher GH; Dabbous FM; Kerlikowske K
    Breast Cancer Res Treat; 2019 Jun; 175(2):519-523. PubMed ID: 30796654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Polygenic Score for Type 2 Diabetes Improves Risk Stratification Beyond Current Clinical Screening Factors in an Ancestrally Diverse Sample.
    Ashenhurst JR; Sazonova OV; Svrchek O; Detweiler S; Kita R; Babalola L; McIntyre M; Aslibekyan S; Fontanillas P; Shringarpure S; ; Pollard JD; Koelsch BL
    Front Genet; 2022; 13():871260. PubMed ID: 35559025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Individualized model for predicting pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: A multicenter study.
    Qian B; Yang J; Zhou J; Hu L; Zhang S; Ren M; Qu X
    Front Endocrinol (Lausanne); 2022; 13():955250. PubMed ID: 36060977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Genome-Wide Polygenic Scores for Multiple Psychiatric and Common Traits in Preadolescent Youths at Risk of Suicide.
    Joo YY; Moon SY; Wang HH; Kim H; Lee EJ; Kim JH; Posner J; Ahn WY; Choi I; Kim JW; Cha J
    JAMA Netw Open; 2022 Feb; 5(2):e2148585. PubMed ID: 35188556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Polygenic Risk Score for Breast Cancer in US Latinas and Latin American Women.
    Shieh Y; Fejerman L; Lott PC; Marker K; Sawyer SD; Hu D; Huntsman S; Torres J; Echeverry M; Bohórquez ME; Martínez-Chéquer JC; Polanco-Echeverry G; Estrada-Flórez AP; ; Haiman CA; John EM; Kushi LH; Torres-Mejía G; Vidaurre T; Weitzel JN; Zambrano SC; Carvajal-Carmona LG; Ziv E; Neuhausen SL
    J Natl Cancer Inst; 2020 Jun; 112(6):590-598. PubMed ID: 31553449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score.
    Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Pedretti RF; Lagioia R; Frigerio M; Catanzaro R; Oliva F
    Int J Cardiol; 2013 Oct; 168(3):2120-6. PubMed ID: 23395457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of Overall Survival Among Female Patients With Breast Cancer Using a Prognostic Signature Based on 8 DNA Repair-Related Genes.
    Zhang D; Yang S; Li Y; Yao J; Ruan J; Zheng Y; Deng Y; Li N; Wei B; Wu Y; Zhai Z; Lyu J; Dai Z
    JAMA Netw Open; 2020 Oct; 3(10):e2014622. PubMed ID: 33017027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women.
    Nickson C; Procopio P; Velentzis LS; Carr S; Devereux L; Mann GB; James P; Lee G; Wellard C; Campbell I
    Breast Cancer Res; 2018 Dec; 20(1):155. PubMed ID: 30572910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.